Asia Pacific Asthma Drugs Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 - COVID-19 Impact and Regional Analysis By Medication (Quick Relief Medications and Long-Term Control Medications), Route of Administration (Inhaled, Prefilled Syringe/Vials, and Others), and Distribution Channel (Online Pharmacies, Hospital Pharmacies, and Retail Pharmacies)

No. of Pages: 153    |    Report Code: BMIRE00025216    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Asia Pacific Asthma Drugs Market

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Asia Pacific Asthma Drugs Market – By Medication

1.3.2        Asia Pacific Asthma Drugs Market – By Route of Administration

1.3.3        Asia Pacific Asthma Drugs Market – By Distribution Channel

1.3.4        Asia Pacific Asthma Drugs Market – By Country

2.           Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Asia Pacific Asthma Drugs Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        Asia Pacific– PEST Analysis

4.3         Expert Opinion

5.           Asthma Drugs Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Growing Environmental Implications & Genetic Implications of Air Pollution

5.1.2        More Vulnerability in Specific Ethnic Groups

5.1.3        Growing Exposure to Coarse Particulate Matters

5.1.4        Growing Prevalence of Physiological Disorders Harboring Asthma

5.2         Market Restraints

5.2.1        Unmet Medical Needs

5.3         Market Opportunities

5.3.1        Opportunities with Commercialization of Biologics

5.4         Future Trends

5.4.1        Increasing Research Activities and Product Innovations

5.5         Impact Analysis

6.           Asthma Drugs Market–Asia Pacific Analysis

6.1         Asia Pacific Asthma Drugs Market Revenue Forecast and Analysis

7.           Asthma Drugs Market Analysis – by Medication

7.1         Overview

7.2         Asthma Drugs Market Revenue Share, by Medication (2021 and 2028)

7.3         Quick Relief Medications

7.3.1        Overview

7.3.2        Quick Relief Medications: Asthma Drugs Market – Revenue and Forecast to 2028 (US$ Million)

7.4         Long-term Control Medications

7.4.1        Overview

7.4.2        Long-term Control Medications: Asthma Drugs Market – Revenue and Forecast to 2028 (US$ Million)

8.           Asthma Drugs Market Analysis – By Route of Administration

8.1         Overview

8.2         Asthma Drugs Market Revenue Share, By Route of Administration (2021 and 2028)

8.3         Inhaled

8.3.1        Overview

8.3.2        Inhaled: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)

8.4         Prefilled Syringe/Vials

8.4.1        Overview

8.4.2        Prefilled Syringe/Vials: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)

8.5         Others (Oral, Nasal, Ophthalmic Etc.)

8.5.1        Overview

8.5.2        Others: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)

9.           Asthma Drugs Market Analysis – By Distribution Channel

9.1         Overview

9.2         Asthma Drugs Market Revenue Share, By Distribution Channel (2021 and 2028)

9.3         Online Pharmacies

9.3.1        Overview

9.3.2        Online Pharmacies: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)

9.4         Hospital Pharmacies

9.4.1        Overview

9.4.2        Hospital Pharmacies: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)

9.5         Retail Pharmacies and Drugstores

9.5.1        Overview

9.5.2        Retail Pharmacies and Drugstores: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)

10.        Asthma Drugs Market – Asia Pacific Analysis

10.1      Asia Pacific: Asthma Drugs Market

10.1.1     Overview

10.1.2     Asia Pacific: Asthma Drugs Market - Revenue and Forecast to 2028 (USD Million)

10.1.3     Asia Pacific: Asthma Drugs Market, by Medication - Revenue and Forecast to 2028 (USD Million)

10.1.4     Asia Pacific: Asthma Drugs Market, by Route of Administration - Revenue and Forecast to 2028  (USD Million)

10.1.5     Asia Pacific: Asthma Drugs Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)

10.1.6     Asia Pacific Asthma Drugs Market Revenue and Forecasts to 2028, By Country (%)

10.1.6.1       India Asthma Drugs Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.6.1.1       India Asthma Drugs Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.6.1.2       India: Asthma Drugs Market, by Medication - Revenue and Forecast to 2028 (USD Million)

10.1.6.1.3       India: Asthma Drugs Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)

10.1.6.1.4       India: Asthma Drugs Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)

10.1.6.2       China Asthma Drugs Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.6.2.1       China Asthma Drugs Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.6.2.2       China: Asthma Drugs Market, by Medication - Revenue and Forecast to 2028 (USD Million)

10.1.6.2.3       China: Asthma Drugs Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)

10.1.6.2.4       China: Asthma Drugs Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)

10.1.6.3       Japan Asthma Drugs Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.6.3.1       Japan Asthma Drugs Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.6.3.2       Japan: Asthma Drugs Market, by Medication - Revenue and Forecast to 2028 (USD Million)

10.1.6.3.3       Japan: Asthma Drugs Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)

10.1.6.3.4       Japan: Asthma Drugs Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)

10.1.6.4       South Korea: Asthma Drugs Market – Revenue and Forecast to 2028 (US$ Thousand)

10.1.6.4.1       South Korea: Asthma Drugs Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.4.2       South Korea: Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (US$ Thousand)

10.1.6.4.3       South Korea: Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Thousand)

10.1.6.4.4       South Korea: Asthma Drugs Market, by Distribution channel – Revenue and Forecast to 2028 (US$ Thousand)

10.1.6.5       Australia: Asthma Drugs Market – Revenue and Forecast to 2028 (US$ Thousand)

10.1.6.5.1       Australia: Asthma Drugs Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.5.2       Australia: Asthma Drugs Market, by Medication– Revenue and Forecast to 2028 (US$ Thousand)

10.1.6.5.3       Australia: Asthma Drugs Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Thousand)

10.1.6.5.4       Australia: Asthma Drugs Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Thousand)

10.1.6.6       Rest of Asia Pacific Asthma Drugs Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.6.6.1       Rest of Asia Pacific Asthma Drugs Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.6.6.2       Rest of Asia Pacific: Asthma Drugs Market, by Medication - Revenue and Forecast to 2028 (USD Million)

10.1.6.6.3       Rest of Asia Pacific: Asthma Drugs Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)

10.1.6.6.4       Rest of Asia Pacific: Asthma Drugs Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)

11.        Asthma Drugs Market–Industry Landscape

11.1      Overview

11.2      Organic Developments

11.2.1     Overview

11.3      Inorganic Developments

11.3.1     Overview

12.        Company Profiles

12.1      AstraZeneca

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      TEVA PHARMACEUTICAL INDUSTRIES LTD

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      GlaxoSmithKline plc.

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      Boehringer Ingelheim International GmbH

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      Merck & Co., Inc.

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      Koninklijke Philips N.V.

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      Sanofi

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8      Pfizer Inc. (Arena Pharmaceutical GmbH)

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

12.9      Novartis AG

12.9.1     Key Facts

12.9.2     Business Description

12.9.3     Products and Services

12.9.4     Financial Overview

12.9.5     SWOT Analysis

12.9.6     Key Developments

12.10   Abbott

12.10.1  Key Facts

12.10.2  Business Description

12.10.3  Products and Services

12.10.4  Financial Overview

12.10.5  SWOT Analysis

12.10.6  Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms

 


LIST OF TABLES

Table 1.             Odds Ratio (OR) For Mental Disorders among Adults with Asthma Vs Without Asthma

Table 2.             Asthma Death Rates for Select Countries, 2018

Table 3.             Common SABAs

Table 4.             Commonly inhaled corticosteroids

Table 5.             Asia Pacific Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (USD Million)

Table 6.             Asia Pacific Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 7.             Asia Pacific Asthma Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 8.             India Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (USD Million)

Table 9.             India Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 10.          India Asthma Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 11.          China Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (USD Million)

Table 12.          China Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 13.          China Asthma Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 14.          Japan Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (USD Million)

Table 15.          Japan Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 16.          Japan Asthma Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 17.          South Korea Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (US$ Thousand)

Table 18.          South Korea Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Thousand)

Table 19.          South Korea Asthma Drugs Market, by Distribution channel – Revenue and Forecast to 2028 (US$ Thousand)

Table 20.          Australia Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (US$ Thousand)

Table 21.          Australia Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Thousand)

Table 22.          Australia Asthma Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Thousand)

Table 23.          Rest of Asia Pacific Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (USD Million)

Table 24.          Rest of Asia Pacific Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 25.          Rest of Asia Pacific Asthma Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 26.          Organic Developments in the Asthma Drugs Market

Table 27.          Inorganic Developments in the Asthma Drugs Market

Table 28.          Glossary of Terms, Asthma Drugs Market

 


LIST OF FIGURES

Figure 1.           Asthma Drugs Market Segmentation

Figure 2.           Asthma Drugs Market, By Country

Figure 3.           Asia Pacific Asthma Drugs Market Overview

Figure 4.           The Long Term Control Medications Segment Held Largest Share of Mode of Service in the Asthma Drugs Market

Figure 6.           Asia Pacific Asthma Drugs Market- Leading Country Markets (US$ Million)

Figure 7.           Asia Pacific PEST Analysis

Figure 8.           Expert Opinion

Figure 9.           Impact of Low Mood/Anxiety on Asthma

Figure 10.        Asthma Drugs Market Impact Analysis of Drivers and Restraints

Figure 11.        Asia Pacific Asthma Drugs Market– Revenue Forecast and Analysis – 2020- 2028

Figure 12.        Asthma Drugs Market Revenue Share, by Medication (2021 and 2028)

Figure 13.        Quick Relief Medications: Asthma Drugs Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Long-term Control Medications: Asthma Drugs Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15.        Asthma Drugs Market Share, By Route of Administration, 2021 and 2028 (%)

Figure 16.        Inhaled: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)

Figure 17.        Prefilled Syringe/Vials: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)

Figure 18.        Others: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)

Figure 19.        Asthma Drugs Market Share, By Distribution Channel, 2021 and 2028 (%)

Figure 20.        Online Pharmacies: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)

Figure 21.        Hospital Pharmacies: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)

Figure 22.        Retail Pharmacies and Drugstores: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)

Figure 23.        Asia Pacific: Asthma Drugs Market, by Key Country – Revenue (2021) (USD Million)

Figure 24.        Asia Pacific Asthma Drugs Market Revenue and Forecast to 2028 (USD Million)

Figure 25.        Asia Pacific Asthma Drugs Market Revenue and Forecasts to 2028, By Country (%)

Figure 26.        India Asthma Drugs Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 27.        China Asthma Drugs Products Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 28.        Japan Asthma Drugs Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 29.        South Korea: Asthma Drugs Market – Revenue and Forecast to 2028 (US$ Thousand)

Figure 30.        Australia: Asthma Drugs Market – Revenue and Forecast to 2028 (US$ Thousand)

Figure 31.        Rest of Asia Pacific Asthma Drugs Market Revenue and Forecasts to 2028 (US$ Mn)

The List of Companies - Asia Pacific Asthma Drugs Market

  1. AstraZeneca
  2. TEVA PHARMACEUTICAL INDUSTRIES LTD
  3. GlaxoSmithKline plc.
  4. Boehringer Ingelheim International GmbH
  5. GlaxoSmithKline plc.
  6. Merck & Co., Inc.
  7. Koninklijke Philips N.V.
  8. Sanofi
  9. Pfizer Inc. (Arena Pharmaceutical GmbH)
  10. Novartis AG
  11. Abbott